10th Aggregate Spend and Open Payments Conference
June 18 - 19, 2019 - Philadelphia NY USExL Pharma
bconetta@exlevents.com
Phone:0000000000
The demand for transparency when looking at the relationship between life science manufacturers and health care providers is at an all-time high. Recent updates to the Physicians Payments Sunshine Act will increase the scope of responsibilities for manufacturers and HCPs alike. Enforcement in the industry is constantly evolving on state, federal and global levels. With differences in reporting requirements, it is up to manufacturers to manage risk, maintain transparency and ensure compliance at all times, which can be extremely difficult. ExL Events is proud to bring you the 10th Aggregate Spend and Open Payments Conference. Over the past nine years, we have had the privilege of educating over 223 organizations and will continue to provide thought-provoking sessions, interactive panels, and spotlight sessions this year. Top Five Reasons to Attend 1. Explore Sunshine Act and Open Payments System updates with the Centers for Medicare and Medicaid Services Director, Robin Usi 2. Interact with DOJ representatives and in-house counsel members to discuss the current enforcement landscape 3. Gain insight from 20+ expert speakers from various backgrounds, including speakers from Boehringer Ingelheim, Daiichi Sankyo, Bayer, Otsuka, Chiesi, Shinogi and more 4. Discuss the best practices for identifying, collecting, and analyzing the data required for open payments reporting 5. Investigate emerging trends and high-risk areas including federal, state and global policies, privacy implications, price transparency, and ethical considerations